Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): A systemic review and meta‐analysis of randomized controlled trials

Abstract Although surgical and interventional therapy has emerged as the primary treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH), there remains a subset of patients who need medication therapy. This study aimed to evaluate the efficacy and safety outcomes of prostac...

Full description

Bibliographic Details
Main Authors: Weijun Li, Xingxue Pang, Jun Chen, Xiaoxia Ren, Huaibing Zhao, Xu Wang, Ning Zhao, Dayi Hu, Zhongyi Jin
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Pulmonary Circulation
Subjects:
Online Access:https://doi.org/10.1002/pul2.70001